Table of Contents
Chapter 1. Global Anti-Infective Agents Market Executive Summary
1.1. Global Anti-Infective Agents Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type/Drug Class
1.3.2. By Route of Administration
1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Anti-Infective Agents Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Anti-Infective Agents Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Infectious Diseases
3.1.2. Antibiotic Resistance
3.1.3. Advancements in Drug Development
3.2. Market Challenges
3.2.1. Regulatory Hurdles
3.2.2. High Cost of Pathology Instruments and Services
3.3. Market Opportunities
3.3.1. Expansion in Emerging Markets
3.3.2. Biotechnology Innovations
Chapter 4. Global Anti-Infective Agents Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Anti-Infective Agents Market Size & Forecasts by Type/Drug Class 2022-2032
5.1. Segment Dashboard
5.2. Global Anti-Infective Agents Market: Type/Drug Class Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Antibacterials
5.2.2. Antivirals
5.2.3. Antifungals
Chapter 6. Global Anti-Infective Agents Market Size & Forecasts by Route of Administration 2022-2032
6.1. Segment Dashboard
6.2. Global Anti-Infective Agents Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Topical
6.2.2. Oral
6.2.3. IV
6.2.4. Others
Chapter 7. Global Anti-Infective Agents Market Size & Forecasts by Distribution Channel 2022-2032
7.1. Segment Dashboard
7.2. Global Anti-Infective Agents Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Specialty Pharmacies
7.2.4. E-Commerce
7.2.5. Others
Chapter 8. Global Anti-Infective Agents Market Size & Forecasts by Region 2022-2032
8.1. North America Anti-Infective Agents Market
8.1.1. U.S. Anti-Infective Agents Market
8.1.1.1. Type/Drug Class breakdown size & forecasts, 2022-2032
8.1.1.2. Route of Administration breakdown size & forecasts, 2022-2032
8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
8.1.2. Canada Anti-Infective Agents Market
8.2. Europe Anti-Infective Agents Market
8.2.1. U.K. Anti-Infective Agents Market
8.2.2. Germany Anti-Infective Agents Market
8.2.3. France Anti-Infective Agents Market
8.2.4. Spain Anti-Infective Agents Market
8.2.5. Italy Anti-Infective Agents Market
8.2.6. Rest of Europe Anti-Infective Agents Market
8.3. Asia-Pacific Anti-Infective Agents Market
8.3.1. China Anti-Infective Agents Market
8.3.2. India Anti-Infective Agents Market
8.3.3. Japan Anti-Infective Agents Market
8.3.4. Australia Anti-Infective Agents Market
8.3.5. South Korea Anti-Infective Agents Market
8.3.6. Rest of Asia Pacific Anti-Infective Agents Market
8.4. Latin America Anti-Infective Agents Market
8.4.1. Brazil Anti-Infective Agents Market
8.4.2. Mexico Anti-Infective Agents Market
8.4.3. Rest of Latin America Anti-Infective Agents Market
8.5. Middle East & Africa Anti-Infective Agents Market
8.5.1. Saudi Arabia Anti-Infective Agents Market
8.5.2. South Africa Anti-Infective Agents Market
8.5.3. Rest of Middle East & Africa Anti-Infective Agents Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Pfizer Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Abbott
9.3.3. Gilead Sciences, Inc.
9.3.4. Bristol-Myers Squibb Company
9.3.5. Merck & Co., Inc.
9.3.6. Sandoz International GmbH
9.3.7. B. Braun SE
9.3.8. Xellia Pharmaceuticals
9.3.9. Mankind Pharma
9.3.10. Bayer AG
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes